Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118023 · ClinicalTrials.gov registry record
7T MRI to Evaluate Cartilage Defects in the Knee
A clinical trial, sponsored by The Methodist Hospital Research Institute.
- Completed
- Registry status
- 112
- Enrollment target
NCT04118023: Completed study, sponsored by The Methodist Hospital Research Institute.
NCT04118023 is a clinical trial that has completed, run by The Methodist Hospital Research Institute. The registered enrollment target is 112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04118023 has completed, sponsored by The Methodist Hospital Research Institute.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
The investigators propose to prospectively evaluate the accuracy of a novel 7-Tesla (7T) knee MRI protocol for the detection and grading of cartilage lesions in the knee, which is a significant limitation of current MRI techniques.
Primary Outcome
* Modified Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee is a validated instrument utilized to grade structural abnormalities found in MRI. * Only the cartilage sub-score of the full WORMS will be scored in the study. Cartilage will be scored on a range from 0-6 for 6 different regional subdivisions for a minimum score of 0 and maximum score of 36. A lower score is considered a better outcome, with a score of 0 equating to normal thickness and signal of cartilage.
Interventions
- DIAGNOSTIC_TEST 7 Tesla Magnetic Resonance Imaging Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2019-10-07 |
| Est. Completion | 2022-09-07 |
What the finished NCT04118023 record still lists
NCT04118023 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 7 Tesla Magnetic Resonance Imaging Test is the first listed.
NCT04118023 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04118023 about?
NCT04118023 is a clinical study titled "7T MRI to Evaluate Cartilage Defects in the Knee". The investigators propose to prospectively evaluate the accuracy of a novel 7-Tesla (7T) knee MRI protocol for the detection and grading of cartilage lesions in the knee, which is a significant limitation of current MRI techniques.
What is the current status of trial NCT04118023?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2019-10-07. Estimated completion is 2022-09-07.
What interventions are being tested in trial NCT04118023?
The interventions under investigation include: 7 Tesla Magnetic Resonance Imaging Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04118023?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI